Long-term treatment with anakinra and canakinumab resolves patellar subchondral erosion in neonatal-onset multisystem inflammatory disease

Reumatismo. 2019 Apr 1;71(1):53-55. doi: 10.4081/reumatismo.2019.1142.

Abstract

Not available.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / therapeutic use*
  • Bone Diseases, Developmental / diagnostic imaging
  • Bone Diseases, Developmental / drug therapy*
  • Cryopyrin-Associated Periodic Syndromes / drug therapy*
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use*
  • Magnetic Resonance Imaging
  • Male
  • Patella* / diagnostic imaging
  • Young Adult

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Interleukin 1 Receptor Antagonist Protein
  • canakinumab